Related Experiment Videos
No pathogenic mutations in the beta-synuclein gene in Parkinson's disease
S Lincoln1, R Crook, M C Chartier-Harlin
1Mayo Clinic Jacksonville, FL 32224, USA. lincoln.sarah@mayo.edu
Neuroscience Letters
|August 3, 1999
Summary
Researchers investigated the beta-synuclein gene as a cause for autosomal dominant Parkinson's disease (PD). Sequencing revealed no pathogenic mutations, suggesting beta-synuclein does not cause PD in these families.
Area of Science:
- Neurogenetics
- Molecular Neurology
- Parkinson's Disease Research
Background:
- Familial Parkinson's disease (PD) can be inherited in an autosomal dominant pattern.
- Mutations in the alpha-synuclein gene are known causes of familial PD.
- The beta-synuclein gene, highly homologous to alpha-synuclein and expressed in the nervous system, was investigated as a potential cause of PD.
Purpose of the Study:
- To investigate the role of the beta-synuclein gene in families with autosomal dominant probable Parkinson's disease.
- To determine if mutations in the beta-synuclein gene are associated with PD in the studied kindreds.
Main Methods:
- Autosomal dominant inheritance patterns were analyzed in 11 families with probable PD.
- Multipoint linkage analysis was performed to assess haplotype sharing at 5q35 among affected family members.
- The translated exons of the beta-synuclein gene were sequenced to identify pathogenic mutations.
Main Results:
- Multipoint linkage analysis provided equivocal results or excluded haplotype sharing at 5q35 in affected family members.
- Sequencing of the beta-synuclein gene's translated exons did not reveal any pathogenic mutations.
- These findings exclude beta-synuclein as a cause of Parkinson's disease in the investigated families.
Conclusions:
- The beta-synuclein gene is not a cause of autosomal dominant Parkinson's disease in the studied families.
- Further research is needed to identify the genetic factors responsible for PD in these kindreds.
- This study highlights the complexity of genetic contributions to Parkinson's disease.